DOUGLAS DAVID: Open Payments
NPI 1396733101 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 66 payments from 18 companies in 2025. Trend: 2023 $1,869 · 2024 $998 · 2025 $1,012
Food & beverage: $993Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $157 |
| GlaxoSmithKline, LLC. | 15 | $149 |
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| Lundbeck LLC | 5 | $92 |
| Lilly USA, LLC | 5 | $76 |
| Amgen Inc. | 5 | $73 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Abbott Laboratories | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: TRELEGY ELLIPTA, REXULTI, JARDIANCE, AIRSUPRA, EVENITY, Ozempic, FARXIGA, Wegovy.
Industry payments across IN — which companies pay providers there.
